Xiaoping Wu of Wanhuida Intellectual Property explains how the CNIPA’s recent invalidation of a sustained-release patent illustrates key considerations in assessing inventive step for pharmaceutical f ...

We spoke to five Australian companies in Vienna seeking collaborators and capital at the BIO Europe partnering conference.

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

BDR Pharma to launch generic version of sunitinib in Indian market by March end: Our Bureau, Mumbai Thursday, February 14, 2013, 14:45 Hrs [IST] Mumbai based BDR Pharma Internatio ...

This study provides a valuable genome-centric characterization of microbial communities across deep sediment cores from a Spartina patens salt marsh. The study provides claims on the metabolic ...